Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
24 May 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
Ozurdex Articles
Regeneron and Bayer’s Eylea backed by thought leaders for DME
13 February 2012
Good news for RVO suffers as EU approves Novartis’ Lucentis and NICE backs Allergan’s Ozurdex
6 June 2011
US FDA approves Bayer’s Beyaz, a combination contraceptive with folate, and Allergan’s Ozurdex
26 September 2010
Europe’s CHMP adopts opinions on Allergan’s Ozurdex and generic leflunomide and use extensions; proposes Zeffix restriction; backs rotavirus vaccine use
24 May 2010
Showing 1-4 of 4 articles
1
Hot Topics
Most Read
Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
Is the diabetes market facing a blockbuster-free future?
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
Is the diabetes market facing a blockbuster-free future?
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth